Urology Care Foundation Announces Recipient of the 2025 Rising Stars in Urology Research Award Dr. de Carvalho’s research ...

In MIBC patients, ctDNA-guided, adjuvant atezolizumab treatment is associated with significant survival improvements over placebo.

Cancer doesn’t discriminate, but Black men in particular have to deal with an increased risk Black men face for ...

Competitive bidding for catheters means reduced patient choice, jeopardized supply chains, and an incentive to push cheap, ...

Neurologist Dr. Priyanka Sehrawat warns against gifting scented candles this festive season. She highlights harmful chemicals ...

New research suggests that ibuprofen, a common over-the-counter painkiller, may help protect against certain types of cancer.

New studies strongly link air pollution to metabolic disorders, cancer and poor brain performance. Protection must go beyond N-95 masks ...

Atezolizumab significantly enhances survival in ctDNA-positive muscle-invasive bladder cancer patients, addressing critical ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced results from the randomized, double-blind, phase 3 ...

On milestones in healthcare and challenges that remain, women’s health, AI and assistive tech, environmental health post ...

A “HOLY grail” blood test can pick up cancer cases with 84 per cent accuracy – even among patients who have been falsely ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new long-term data highlighting the sustained survival benefits of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 ...